Similar articles

• [Relation of monoamines to mental disorders].

  Rysánek K. Rysánek K. Act Nerv Super (Praha). 1970;12(2):97-108. Act Nerv Super (Praha). 1970. PMID: 4913937 Review. Czech. No abstract available.
• [The drug experience as a biological problem].

  Stille G. Stille G. Schweiz Med Wochenschr. 1971 Sep 4;101(35):1257-69. Schweiz Med Wochenschr. 1971. PMID: 4947024 Review. German. No abstract available.
• N,N-dimethyltryptamine--a possible relationship to schizophrenia?

  Wyatt RJ, Gillin JC, Kaplan J, Stillman R, Mandel L, Ahn HS, VandenHeuvel WJ, Walker RW. Wyatt RJ, et al. Adv Biochem Psychopharmacol. 1974;11(0):299-313. Adv Biochem Psychopharmacol. 1974. PMID: 4602668 Review. No abstract available.
• Indoleamines and the central nervous system; a sounding of their clinical significance.

  van Praag HM. van Praag HM. Psychiatr Neurol Neurochir. 1970 Jan-Feb;73(1):9-36. Psychiatr Neurol Neurochir. 1970. PMID: 4313906 Review. No abstract available.
• Molecular pharmacology of hallucinogens.

  Johnston VS, Bradley RJ. Johnston VS, et al. Recent Adv Biol Psychiatry. 1968;10:74-99. doi: 10.1007/978-1-4684-9072-5_8. Recent Adv Biol Psychiatry. 1968. PMID: 4872761 Review. No abstract available.